Article
Random forest-based modelling to detect biomarkers for prostate cancer progression
22 Oct 2019
Abstract excerpt
BACKGROUND: The clinical course of prostate cancer (PCa) is highly variable, demanding an individualized approach to therapy. Overtreatment of indolent PCa cases, which likely do not progress to aggressive stages, may be associated with severe side effects and considerable costs. These could be avoided by utilizing robust prognostic markers to guide treatment decisions. RESULTS: We present a random forest-based...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
